Menicon Co (7780.T) Stock Price

Menicon Co Price

JPX·CLOSED
1,875.00
​
Market closed

Over the last 13 years Menicon Co grew revenue by 6.1% annually, reaching 125.61 B JPY. Earnings per share have grown at 15.3% per year over the last 13 years. For Menicon Co, the net margin of 4.7% is down versus 6.5% a few years ago. At today's price the dividend yield works out to roughly 2.99%. The payout ratio is around 37% of earnings. The dividend has grown at 22.3% per year over the past 10 years. The consensus 12-month price target for Menicon Co is 1,530.00 JPY, about 18.4% below where the stock trades today. Of 9 analysts, 6 rate the stock a buy — an overall Buy consensus.

Menicon Co stock price

Access this data via the Eulerpool API

Menicon Co business model & stock analysis

Menicon Co Ltd is a Japanese company in the ophthalmology industry and was founded in 1951 by Kyoichi Tanaka. Over the past decades, the company has become a global player and is now one of the largest contact lens manufacturers worldwide. The history of Menicon began with the development of the first rigid contact lens in Japan. In 1972, the company introduced its first soft contact lens to the market, revolutionizing the contact lens industry. In the 1980s, the company expanded internationally and opened distribution offices in the US and Europe. Today, Menicon is present in more than 90 countries. The company specializes in the manufacture of contact lenses, contact lens care products, and optical products. Menicon's goal is to develop products that are safe for eye health and improve customer's visual quality. Menicon's business model is based on collaboration with partners, experts, and institutions in the ophthalmology industry. Menicon invests in research and development and strives to bring innovative products to the market. The company has received a number of patents for its products and is constantly working to improve them. Menicon is divided into different divisions to meet the needs of different customers. The Menicon main brand focuses on rigid contact lenses and offers various products for people with poor eyesight. The Menicon Bloom Myopia contact lenses are specifically designed for children with myopia and aim to slow down the progression of nearsightedness. Menicon also offers a specialty range for astigmatism correction, and a product line called Menicon Z offers unique options for correcting corneal irregularities. For patients suffering from dry eyes, Menicon provides various soft contact lenses and solutions. In addition to contact lenses and care products, Menicon also produces optical products such as glasses and sunglasses. The company also has an online platform where customers have the opportunity to purchase eyewear and contact lenses online. The company strives for sustainability and environmentally friendly production. Menicon uses recyclable material for their products and aims for comprehensive waste disposal. The company is also a member of "Eco Vision 2025," an initiative to reduce environmental impact and promote a sustainable society. Overall, Menicon is a company that focuses on quality and innovation and seeks to meet the needs of the ophthalmology industry. With its decades of experience and presence in the market, it has become a trusted partner for professionals and customers.

Frequently asked questions about Menicon Co

The business model of Menicon Co Ltd is primarily focused on the manufacturing and selling of contact lenses and related products. Menicon specializes in the development of high-quality and technologically advanced contact lenses that cater to different vision needs. The company aims to provide comfortable and safe vision correction solutions to customers worldwide. Menicon's business strategy includes continuous research and development, maintaining manufacturing facilities, and establishing distribution networks to ensure the availability of their products in the global market. By offering innovative lens designs and addressing various eye care requirements, Menicon aims to contribute to the overall improvement of eye health and provide optimal visual comfort for its customers.

Menicon Co Ltd is primarily active in the industries of contact lenses and eye care products.

The main competitors of Menicon Co Ltd in the market include companies such as Johnson & Johnson, Bausch Health Companies Inc., and CooperVision Inc.

Menicon Co Ltd is a renowned company specializing in the manufacture and distribution of contact lenses and related products. Founded in 1951 by Kyoichi Tanaka, Menicon has since established itself as a global leader in the eye care industry. Over the years, the company has consistently demonstrated its commitment to innovation, quality, and customer satisfaction. With its headquarters in Nagoya, Japan, Menicon has expanded its operations worldwide, catering to the needs of millions of contact lens wearers. Menicon's extensive history and expertise in the field have earned it a prestigious reputation among consumers and professionals alike.

Menicon Co Ltd has achieved significant milestones in its history. Some notable achievements include the development of the world's first disposable soft contact lenses, the launch of innovative lens care solutions, and the establishment of production facilities worldwide. Menicon introduced innovative lens materials like Menicon Z and Miru 1day Flat Pack lenses, revolutionizing the contact lens industry. The company also pioneered orthokeratology, a non-surgical vision correction method. Menicon Co Ltd has consistently focused on research and development, ensuring continuous innovation and providing quality vision care products to customers worldwide.

Menicon Co Ltd is primarily present in various countries and regions worldwide. The company has a significant presence in Japan, where it is headquartered. Additionally, Menicon Co Ltd has expanded its operations to other countries, including the United States, China, Europe, and many parts of Asia. With its global reach, Menicon Co Ltd has established a strong foothold in the eyecare industry, offering a wide range of contact lenses, lens care products, and other vision care solutions.

Menicon Co Ltd represents the values of innovation, quality, and sustainability in its corporate philosophy. As a global leader in contact lenses and eye care products, Menicon is committed to providing innovative solutions that improve vision and enhance the quality of life for its customers. With a strong focus on research and development, Menicon continually strives to develop new technologies and products that meet the evolving needs of the eye care industry. Sustainability also plays a crucial role in Menicon's corporate philosophy, as the company is dedicated to minimizing its environmental impact and promoting social responsibility.

Analysts currently set an average price target of 1,723.80 JPY for the Menicon Co stock (median: 1,530.00 JPY), implying -8.1 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Menicon Co stock: 6 recommend buying, 3 holding and 0 selling.

Converted at the current exchange rate, the Menicon Co share trades at 10.59 EUR (1,875.00 JPY).

The Menicon Co share (7780.T) is listed on 3 stock exchanges, including: Tokio (JPX) (7780.T), Frankfurt (5FR.F), Düsseldorf (5FR.DU).

The Menicon Co Ltd is a Japanese company specializing in the manufacture and distribution of contact lenses, eye care products, and medical devices. The company was founded in 1951 and is headquartered in Nagoya, Japan. The company has various business segments, including contact lenses, eye care products, and medical devices. In the contact lenses division, Menicon offers a wide range of lenses for correcting nearsightedness, farsightedness, and astigmatism. The lines range from daily disposable lenses to custom-made lenses for individuals with special needs. Some of the popular products in this division are the Menicon Z Night lenses, designed for correcting nearsightedness while sleeping, and the Menicon Bloom lenses, made from a material that minimizes allergic reactions. In the eye care products segment, Menicon offers cleaning solutions for contact lenses and eye drops to reduce irritation and dryness. The line includes a variety of care products, including a special cleaning solution for individuals with sensitive eyes. In the medical devices division, Menicon manufactures various instruments and devices for ophthalmology, including surgical instruments for cataract and retinal surgeries, and tonometers for measuring intraocular pressure. The company has also developed and patented innovative technologies such as the Menicon Bloom Custom Ortho-K System, which can contribute to improving visual acuity. Menicon is an international brand that is represented in over 90 countries worldwide and has built important partnerships with leading companies in the field of ophthalmology. In addition to producing and distributing contact lenses and eye care products, the company also aims to take a leading position in the research and development of eye health technologies. Menicon's business model is focused on offering high-quality products at an affordable price. The company has a strong customer orientation by supporting professionals in optics and ophthalmology to educate consumers about the quality and benefits of its products. Menicon is also an environmentally conscious company that strives to act responsibly and promote sustainable business practices. Overall, Menicon has become one of the leading companies in the eye industry by combining innovative technology with high quality and user-friendliness of its products. By combining expertise and innovation, the company has further improved its position in a competitive market and its alignment with customer-centric and sustainable business practices.

The revenue of Menicon Co is 125.61 B JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of Menicon Co is 5.92 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Menicon Co is currently 23.65. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Menicon Co stock.

The price-to-sales ratio (P/S) of Menicon Co is currently 1.11. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Menicon Co stock.

The Eulerpool Quality Score for Menicon Co is 5/10.

The ISIN of Menicon Co is JP3921270009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Menicon Co is A14VFU. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Menicon Co is 7780.T. The ticker symbol is used to trade Menicon Co shares on the stock exchange.

Fair ValueTerminal
1,762.50 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
38.48 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
JPY
Initial public offering
Jun 25, 2015
ISIN
JP3921270009
Cusip
J4229M108
Sedol
BYL7K85
Market capitalization
152.41 B JPYLarge Cap
52-Week Range
PEG
1.96
P/E ratio
P/Ee 2027
19.94
P/Ee 2028
16.72
P/Ee 2029
14.82
P/Ee 2030
12.17
P/Ee 2031
11.29
P/S
P/Se
1.05
EV/EBIT
18.95
P/B Ratio
1.60
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.50 %
Dividend
Dividend yield
2.99 %
Est. Dividend Yield
2.99 %
Payout Ratio
36.86 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
10 years
Dividend not reduced since
10 years
Dividend increased since
1 year
Dividend withholding tax
15.32 %
Last updated Oct 13, 2026, 6:26 PM

Menicon Co Ticker

DÜSSELDORF · 5FR.DUFRANKFURT · 5FR.FJPX · 7780.T

Menicon Co FIGI

7780:JP · BBG000PNYP537780:JT · BBG0096K4TQ37780:JN · BBG0096K4TT07780:JJ · BBG0096K4VK47780:JE · BBG0096K4VS67780:JI · BBG0096K4VW17780:JU · BBG0096K4VZ87780:JW · BBG0096K4W13MNNLF:US · BBG00HPD8WQ9MNNLF:PQ · BBG00HPD8X32MNNLF:UV · BBG00HPD8X417780JPY:X2 · BBG00JYS6R85